Axial spondyloarthritis classification criteria

The debate continues

Maureen Dubreuil, Atulya (Atul) Deodhar

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Purpose of review The Assessment of Spondyloarthritis International Society (ASAS) axial spondyloarthritis (axSpA) classification criteria marked a major step forward in SpA research, distinguishing axial from peripheral disease, and allowing earlier identification through MRI. This facilitated all aspects of research including epidemiology, therapeutics and patient outcomes. Recent findings The ASAS axSpA classification criteria have been applied broadly in research, and were validated in a recent meta-analysis of international studies. Concerns arose because of clinical differences between the clinical and imaging arms, which imply different risk for radiographic progression, and perform differently in validation studies. Low specificity of the MRI finding of sacroiliac joint bone marrow edema may lead to misclassification in populations with low axSpA prevalence. We suggest methodology to improve upon the criteria, including rigorous assessment of potential candidate criteria sets, discrete choice experiments to allow consideration of feature weights, and validation. Separately, assessment of structural and inflammatory MRI abnormalities should be performed to refine the MRI definition of sacroiliitis. Summary The debate regarding the validation and modification of the ASAS axSpA classification criteria should lead to international efforts to build upon the gains made by these criteria, to further refine the axSpA population definitions for research and ultimately improve patient outcomes.

Original languageEnglish (US)
Pages (from-to)317-322
Number of pages6
JournalCurrent Opinion in Rheumatology
Volume29
Issue number4
DOIs
StatePublished - Jul 1 2017

Fingerprint

Research
Sacroiliitis
Sacroiliac Joint
Validation Studies
Population
Meta-Analysis
Edema
Epidemiology
Bone Marrow
Weights and Measures
Therapeutics

Keywords

  • classification
  • outcomes research
  • spondyloarthritis

ASJC Scopus subject areas

  • Rheumatology

Cite this

Axial spondyloarthritis classification criteria : The debate continues. / Dubreuil, Maureen; Deodhar, Atulya (Atul).

In: Current Opinion in Rheumatology, Vol. 29, No. 4, 01.07.2017, p. 317-322.

Research output: Contribution to journalReview article

@article{102211cf132c47c4982755fc39de3262,
title = "Axial spondyloarthritis classification criteria: The debate continues",
abstract = "Purpose of review The Assessment of Spondyloarthritis International Society (ASAS) axial spondyloarthritis (axSpA) classification criteria marked a major step forward in SpA research, distinguishing axial from peripheral disease, and allowing earlier identification through MRI. This facilitated all aspects of research including epidemiology, therapeutics and patient outcomes. Recent findings The ASAS axSpA classification criteria have been applied broadly in research, and were validated in a recent meta-analysis of international studies. Concerns arose because of clinical differences between the clinical and imaging arms, which imply different risk for radiographic progression, and perform differently in validation studies. Low specificity of the MRI finding of sacroiliac joint bone marrow edema may lead to misclassification in populations with low axSpA prevalence. We suggest methodology to improve upon the criteria, including rigorous assessment of potential candidate criteria sets, discrete choice experiments to allow consideration of feature weights, and validation. Separately, assessment of structural and inflammatory MRI abnormalities should be performed to refine the MRI definition of sacroiliitis. Summary The debate regarding the validation and modification of the ASAS axSpA classification criteria should lead to international efforts to build upon the gains made by these criteria, to further refine the axSpA population definitions for research and ultimately improve patient outcomes.",
keywords = "classification, outcomes research, spondyloarthritis",
author = "Maureen Dubreuil and Deodhar, {Atulya (Atul)}",
year = "2017",
month = "7",
day = "1",
doi = "10.1097/BOR.0000000000000402",
language = "English (US)",
volume = "29",
pages = "317--322",
journal = "Current Opinion in Rheumatology",
issn = "1040-8711",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Axial spondyloarthritis classification criteria

T2 - The debate continues

AU - Dubreuil, Maureen

AU - Deodhar, Atulya (Atul)

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Purpose of review The Assessment of Spondyloarthritis International Society (ASAS) axial spondyloarthritis (axSpA) classification criteria marked a major step forward in SpA research, distinguishing axial from peripheral disease, and allowing earlier identification through MRI. This facilitated all aspects of research including epidemiology, therapeutics and patient outcomes. Recent findings The ASAS axSpA classification criteria have been applied broadly in research, and were validated in a recent meta-analysis of international studies. Concerns arose because of clinical differences between the clinical and imaging arms, which imply different risk for radiographic progression, and perform differently in validation studies. Low specificity of the MRI finding of sacroiliac joint bone marrow edema may lead to misclassification in populations with low axSpA prevalence. We suggest methodology to improve upon the criteria, including rigorous assessment of potential candidate criteria sets, discrete choice experiments to allow consideration of feature weights, and validation. Separately, assessment of structural and inflammatory MRI abnormalities should be performed to refine the MRI definition of sacroiliitis. Summary The debate regarding the validation and modification of the ASAS axSpA classification criteria should lead to international efforts to build upon the gains made by these criteria, to further refine the axSpA population definitions for research and ultimately improve patient outcomes.

AB - Purpose of review The Assessment of Spondyloarthritis International Society (ASAS) axial spondyloarthritis (axSpA) classification criteria marked a major step forward in SpA research, distinguishing axial from peripheral disease, and allowing earlier identification through MRI. This facilitated all aspects of research including epidemiology, therapeutics and patient outcomes. Recent findings The ASAS axSpA classification criteria have been applied broadly in research, and were validated in a recent meta-analysis of international studies. Concerns arose because of clinical differences between the clinical and imaging arms, which imply different risk for radiographic progression, and perform differently in validation studies. Low specificity of the MRI finding of sacroiliac joint bone marrow edema may lead to misclassification in populations with low axSpA prevalence. We suggest methodology to improve upon the criteria, including rigorous assessment of potential candidate criteria sets, discrete choice experiments to allow consideration of feature weights, and validation. Separately, assessment of structural and inflammatory MRI abnormalities should be performed to refine the MRI definition of sacroiliitis. Summary The debate regarding the validation and modification of the ASAS axSpA classification criteria should lead to international efforts to build upon the gains made by these criteria, to further refine the axSpA population definitions for research and ultimately improve patient outcomes.

KW - classification

KW - outcomes research

KW - spondyloarthritis

UR - http://www.scopus.com/inward/record.url?scp=85017126015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017126015&partnerID=8YFLogxK

U2 - 10.1097/BOR.0000000000000402

DO - 10.1097/BOR.0000000000000402

M3 - Review article

VL - 29

SP - 317

EP - 322

JO - Current Opinion in Rheumatology

JF - Current Opinion in Rheumatology

SN - 1040-8711

IS - 4

ER -